In 2013, a key theme of research in renal transplantation was the diagnosis of rejection. Data from key studies published in the past year highlight aspects of rejection that warrant further investigation and should prompt the consideration of adjunctive tests to complement traditional histological assessment of allograft biopsy samples.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Metabolomics identifies metabolite biomarkers associated with acute rejection after heart transplantation in rats
Scientific Reports Open Access 13 November 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Reeve, J. et al. Molecular diagnosis of T cell-mediated rejection in human kidney transplant biopsies. Am. J. Transplant. 13, 645–655 (2013).
Sellarés, J. et al. Molecular diagnosis of antibody-mediated rejection in human kidney transplants. Am. J. Transplant. 13, 971–983 (2013).
Halloran, P. F. et al. Potential impact of microarray diagnosis of T cell-mediated rejection in kidney transplants: the INTERCOM study. Am. J. Transplant. 13, 2352–2363 (2013).
Halloran, P. F. et al. Microarray diagnosis of antibody-mediated rejection in kidney transplant biopsies: an international prospective study (INTERCOM). Am. J. Transplant. 13, 2865–2874 (2013).
Furness, P. N. et al. International variation in histologic grading is large, and persistent feedback does not improve reproducibility. Am. J. Surg. Path. 27, 805–810 (2003).
Mengel, M. et al. Banff initiative for quality assurance in transplantation (BIFQUIT): reproducibility of C4d immunohistochemistry in kidney allografts. Am. J. Transplant. 13, 1235–1245 (2013).
Lefaucheur, C. et al. Antibody-mediated vascular rejection of kidney allografts: a population-based study. Lancet 381, 313–319 (2013).
Suthanthiran, M. et al. Urinary-cell mRNA profile and acute cellular rejection in kidney allografts. N. Engl. J. Med. 369, 20–31 (2013).
Ingelfinger, J. R. & Alexander, S. I. One step closer to “Rejectostix.” N. Engl. J. Med. 369, 84–85 (2013).
Loupy, A. et al. Complement-binding anti-HLA antibodies and kidney-allograft survival. N. Engl. J. Med. 369, 1215–1226 (2013).
Acknowledgements
N. A. Zwang thanks the Brigham and Women's Hospital/Massachusetts General Hospital Joint Nephrology Fellowship Program.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
L. A. Turka is married to an employee of Novartis. N. A. Zwang declares no competing interests.
Rights and permissions
About this article
Cite this article
Zwang, N., Turka, L. New approaches to diagnosis of rejection. Nat Rev Nephrol 10, 72–74 (2014). https://doi.org/10.1038/nrneph.2013.262
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2013.262